Skip to main content
OpenTrials

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

118 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

NCT03615482

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Achieve Clinical Research, LLC ( Site 0046) Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. ( Site 0039) Chandler, Arizona, United States
  • Synexus Clinical Research, US,Inc/Central Arizona Medical Associates, PC ( Site 0004) Mesa, Arizona, United States
  • Synexus Clinical Research US, Inc. ( Site 0042) Scottsdale, Arizona, United States
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

NCT03565900

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Stanford Health Care ( Site 0005) Palo Alto, California, United States
  • Children's Hospital Colorado ( Site 0166) Aurora, Colorado, United States
  • University of Florida ( Site 0011) Gainesville, Florida, United States
  • University of Chicago ( Site 0016) Chicago, Illinois, United States
View all 52 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)

NCT04031846

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Queensland Children s Hospital ( Site 0004) South Brisbane, Queensland, Australia
  • Vaccine and Immunisation Research Group - VIRGo ( Site 0002) Melbourne, Victoria, Australia
  • Telethon Kids Institute ( Site 0003) Nedlands, Australia
  • O.L.V. Ziekenhuis Aalst ( Site 0144) Aalst, Belgium
View all 60 locations
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

NCT04384107

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Morinaga Maternity Clinic ( Site 3345) Kasugai, Aichi-ken, Japan
  • Social Medical Corporation Koujunkai Daido Clinic ( Site 3326) Nagoya, Aichi-ken, Japan
  • Kyoritsu Narashinodai Hospital ( Site 3332) Funabashi, Chiba, Japan
  • Sotobo Children's Clinic ( Site 3323) Isumi, Chiba, Japan
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

NCT03692871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Premier Health Research Center, LLC ( Site 0005) Downey, California, United States
  • Beach Pediatrics ( Site 0040) Huntington Beach, California, United States
  • Khruz Biotechnology Research Institute ( Site 0006) San Diego, California, United States
  • Kaiser Permanente - San Jose ( Site 0036) San Jose, California, United States
View all 76 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

NCT03893448

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Alabama Clinical Therapeutics ( Site 0159) Birmingham, Alabama, United States
  • Southeastern Pediatric Associates, P.A. ( Site 0107) Dothan, Alabama, United States
  • South Alabama Pediatrics ( Site 0263) Opp, Alabama, United States
  • Northwest Arkansas Pediatric Clinic ( Site 0172) Fayetteville, Arkansas, United States
View all 81 locations
View Trial Details

Related conditions